e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Baxter International
(NY:
BAX
)
19.93
-2.34 (-10.53%)
Streaming Delayed Price
Updated: 11:01 AM EST, Feb 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Baxter International
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Baxter (BAX) Q4 2025 Earnings Call Transcript
↗
Today 11:10 EST
Baxter (BAX) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
Thursday's session: gap up and gap down stock in the S&P500 index
↗
Today 10:35 EST
Via
Chartmill
Get insights into the top movers in the S&P500 index of Thursday's pre-market session.
↗
Today 8:35 EST
Via
Chartmill
Baxter International Inc (NYSE:BAX) Stock Plummets on Q4 Earnings Miss and Weak 2026 Outlook
↗
Today 8:28 EST
Via
Chartmill
Topics
Earnings
The Dialysis Renaissance: How DaVita (DVA) Conquered the GLP-1 Fear and Defined Healthcare Resilience in 2026
February 11, 2026
Date: February 11, 2026 Introduction In the first few weeks of 2026, a singular healthcare name has dominated the screens of institutional traders and retail investors alike: DaVita Inc. (NYSE: DVA)....
Via
Finterra
Topics
Bankruptcy
Earnings
Retirement
Gapping S&P500 stocks in Monday's session
↗
January 12, 2026
Via
Chartmill
Pure-Play Pivot: A Deep Dive into Becton Dickinson (BDX) Following the Waters Spin-Off and 2026 Guidance Reset
February 11, 2026
Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not...
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Baxter (BAX) Q4 Earnings: What To Expect
February 10, 2026
Via
StockStory
Topics
Artificial Intelligence
World Trade
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
February 09, 2026
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...
Via
Finterra
Topics
Artificial Intelligence
Economy
Product Recall
Is Baxter International an Underrated Healthcare Investment Play?
↗
February 06, 2026
Baxter International is in turnaround mode, but a recent dividend decision will keep many investors away.
Via
The Motley Fool
These S&P500 stocks that are showing activity before the opening bell on Friday.
↗
January 30, 2026
Via
Chartmill
1 Stock Under $50 with Impressive Fundamentals and 2 We Question
January 15, 2026
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...
Via
StockStory
Top S&P500 movers in Monday's session
↗
January 12, 2026
Via
Chartmill
Why Baxter (BAX) Stock Is Trading Lower Today
January 12, 2026
Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays lowered its price target on the stock to $30 from $36, signaling a more cautious outlook...
Via
StockStory
Topics
Artificial Intelligence
Supply Chain
What's going on in today's session: S&P500 movers
↗
January 12, 2026
Via
Chartmill
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
December 26, 2025
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare...
Via
PredictStreet
Topics
Economy
Emissions
Product Recall
Q3 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
December 10, 2025
Looking back on medical devices & supplies - diversified stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Baxter (NYSE:BAX) and its peers.
Via
StockStory
3 of Wall Street’s Favorite Stocks We Think Twice About
December 07, 2025
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...
Via
StockStory
Topics
Firearms
2 Volatile Stocks with Exciting Potential and 1 We Question
December 02, 2025
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...
Via
StockStory
Topics
Credit Cards
ETFs
These S&P500 stocks are moving in today's session
↗
November 28, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Via
Chartmill
CooperCompanies, iRhythm, Baxter, Omnicell, and Neogen Shares Skyrocket, What You Need To Know
November 21, 2025
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...
Via
StockStory
Topics
Artificial Intelligence
Economy
Stocks
2 Cash-Producing Stocks Worth Your Attention and 1 That Underwhelm
November 13, 2025
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Via
StockStory
3 Reasons to Avoid BAX and 1 Stock to Buy Instead
November 11, 2025
Shareholders of Baxter would probably like to forget the past six months even happened. The stock dropped 43.3% and now trades at $18.09. This was partly driven by its softer quarterly results and...
Via
StockStory
Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter
↗
November 11, 2025
Greenhaven Bets Over $143 Million on a Turnaround at Medical Devices Leader Baxter
Via
The Motley Fool
3 Reasons BAX is Risky and 1 Stock to Buy Instead
November 10, 2025
Baxter has gotten torched over the last six months - since May 2025, its stock price has dropped 44.3% to $17.76 per share. This was partly driven by its softer quarterly results and might have...
Via
StockStory
Looking Into Baxter International Inc's Recent Short Interest
↗
November 07, 2025
Via
Benzinga
Baxter’s Q3 Earnings Call: Our Top 5 Analyst Questions
November 06, 2025
Baxter’s third quarter results were met with a negative market reaction, as the company delivered top-line growth but missed Wall Street’s revenue expectations. Management attributed performance...
Via
StockStory
Topics
Earnings
1 Stock Under $50 to Target This Week and 2 We Brush Off
November 05, 2025
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...
Via
StockStory
Why Baxter (BAX) Shares Are Sliding Today
October 31, 2025
Shares of healthcare company Baxter International (NYSE:BAX) fell 2.9% in the afternoon session after the stock continued to fall as the company reported mixed third-quarter results, lowered its...
Via
StockStory
Topics
Earnings
Exploring the top movers within the S&P500 index during today's session.
↗
October 31, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.